Matches in SemOpenAlex for { <https://semopenalex.org/work/W3047373345> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W3047373345 abstract "Search for new biologically active compounds includes the directed design of molecules based on the so-called structural blocks – usually the privileged (structures, to which the 4-thiazolidinone cycle belongs. Therefore the development of methods for the synthesis of small drug-like molecules from 2-cyanomethylidene-4-thiazolidinone group as well as the study of their biological profile is an urgent task for modern medicinal chemistry.Aim. To design and to the synthesis of novel 5-ylidene derivatives of 2-cyano-2-(4-oxo-3-phenylthiazolidin-2-ylidene)-N-arylacetamides. Study of the antitumor activity of synthesized compounds.Materials and methods. Organic synthesis, study of the spectral characteristics of obtained 4-thiazolidinones (1H and 13C NMR spectroscopy, LC- MS spectrometry). In vitro antitumor activity study according to the DTP Program of the National Cancer Institute (USA).Results. A number of 5-substituted 2-cyano-2-(4-oxo-3-phenylthiazolidin-2-ylidene)-N-arylacetamide derivatives had been synthesized. The structure and purity of the synthesized compounds were confirmed by the methods of elemental analysis, 1H, 13C NMR spectroscopy and LC-MS. The antitumor activity of some of the synthesized compounds was investigated on a panel of 59 human tumor cell lines representing nine neoplastic diseases.Conclusions. Based on the C5 modification of the methylene group of the 4-thiazolidinone cycle, the target 5-ylidene and 5-aminomethylene-2-cyano-2-(4-oxo-3-phenylthiazolidin-2-ylidene)-N-arylacetamides had been synthesized. A hit-compound 2-cyano-2-[5-[(4-methoxyphenyl)methylene]-4-oxo-3-phenylthiazolidin-2-ylidene]-N-arylacetamide was identified that selectively inhibited the growth of some cell lines of CNS, kidney and breast cancers." @default.
- W3047373345 created "2020-08-10" @default.
- W3047373345 creator A5004737073 @default.
- W3047373345 date "2020-07-03" @default.
- W3047373345 modified "2023-10-11" @default.
- W3047373345 title "Synthesis and anticancer activity of 2-cyano-2-(4-oxo-3-phenylthiazolidin-2-ylidene)-N-arylacetamides" @default.
- W3047373345 cites W1929853724 @default.
- W3047373345 cites W1987632177 @default.
- W3047373345 cites W2018037575 @default.
- W3047373345 cites W2021431802 @default.
- W3047373345 cites W2028733293 @default.
- W3047373345 cites W2052434638 @default.
- W3047373345 cites W2087312216 @default.
- W3047373345 cites W2090100414 @default.
- W3047373345 cites W2118909720 @default.
- W3047373345 cites W2126508060 @default.
- W3047373345 cites W2130802109 @default.
- W3047373345 cites W2139718202 @default.
- W3047373345 cites W2155208683 @default.
- W3047373345 cites W2162194005 @default.
- W3047373345 cites W2163269528 @default.
- W3047373345 cites W2173360254 @default.
- W3047373345 cites W2318527110 @default.
- W3047373345 cites W2507508898 @default.
- W3047373345 cites W25117316 @default.
- W3047373345 cites W2586236648 @default.
- W3047373345 cites W2755756968 @default.
- W3047373345 cites W2761380851 @default.
- W3047373345 cites W2808353221 @default.
- W3047373345 cites W2889521122 @default.
- W3047373345 cites W2949915207 @default.
- W3047373345 cites W2951440100 @default.
- W3047373345 cites W355515766 @default.
- W3047373345 cites W2519764274 @default.
- W3047373345 doi "https://doi.org/10.14739/2409-2932.2020.2.207100" @default.
- W3047373345 hasPublicationYear "2020" @default.
- W3047373345 type Work @default.
- W3047373345 sameAs 3047373345 @default.
- W3047373345 citedByCount "0" @default.
- W3047373345 crossrefType "journal-article" @default.
- W3047373345 hasAuthorship W3047373345A5004737073 @default.
- W3047373345 hasBestOaLocation W30473733451 @default.
- W3047373345 hasConcept C103319777 @default.
- W3047373345 hasConcept C155647269 @default.
- W3047373345 hasConcept C163111631 @default.
- W3047373345 hasConcept C178790620 @default.
- W3047373345 hasConcept C185592680 @default.
- W3047373345 hasConcept C202751555 @default.
- W3047373345 hasConcept C21951064 @default.
- W3047373345 hasConcept C2777454769 @default.
- W3047373345 hasConcept C32909587 @default.
- W3047373345 hasConcept C55493867 @default.
- W3047373345 hasConcept C66974803 @default.
- W3047373345 hasConcept C71240020 @default.
- W3047373345 hasConceptScore W3047373345C103319777 @default.
- W3047373345 hasConceptScore W3047373345C155647269 @default.
- W3047373345 hasConceptScore W3047373345C163111631 @default.
- W3047373345 hasConceptScore W3047373345C178790620 @default.
- W3047373345 hasConceptScore W3047373345C185592680 @default.
- W3047373345 hasConceptScore W3047373345C202751555 @default.
- W3047373345 hasConceptScore W3047373345C21951064 @default.
- W3047373345 hasConceptScore W3047373345C2777454769 @default.
- W3047373345 hasConceptScore W3047373345C32909587 @default.
- W3047373345 hasConceptScore W3047373345C55493867 @default.
- W3047373345 hasConceptScore W3047373345C66974803 @default.
- W3047373345 hasConceptScore W3047373345C71240020 @default.
- W3047373345 hasLocation W30473733451 @default.
- W3047373345 hasOpenAccess W3047373345 @default.
- W3047373345 hasPrimaryLocation W30473733451 @default.
- W3047373345 hasRelatedWork W10920705 @default.
- W3047373345 hasRelatedWork W11710135 @default.
- W3047373345 hasRelatedWork W19081369 @default.
- W3047373345 hasRelatedWork W25850576 @default.
- W3047373345 hasRelatedWork W26133156 @default.
- W3047373345 hasRelatedWork W27258062 @default.
- W3047373345 hasRelatedWork W29829592 @default.
- W3047373345 hasRelatedWork W31614972 @default.
- W3047373345 hasRelatedWork W33828502 @default.
- W3047373345 hasRelatedWork W6559404 @default.
- W3047373345 isParatext "false" @default.
- W3047373345 isRetracted "false" @default.
- W3047373345 magId "3047373345" @default.
- W3047373345 workType "article" @default.